Sun. Dec 22nd, 2024

Brussels, 5 December 20254

Joint press release by the EU Commission and the European Council on the EU and the Bill & Melinda Gates Foundation co-hosting the Gavi High Level Pledging Summit

The European Union and the Gates Foundation, together with the close support of other Gavi donors and implementing countries, will co-host the Gavi 6.0 pledging Summit. The event is planned to take place in Brussels late in the first quarter of 2025. It will bring together global leaders from government, partner organisations, vaccine manufacturers, civil society and the private sector, to secure crucial investments in vaccination programmes.

President of the European Commission, Ursula von der Leyen said:

“In today’s world, addressing health challenges at the global level is more important than ever. Vaccines have a lifesaving power. And Gavi’s role is key for making equitable vaccine access a reality, and for empowering our partners to achieve health sovereignty. Together with Gavi, we have the goal to vaccinate 500 million children by 2030. That is why the European Union is proud to co-host Gavi’s High Level Pledging Summit in Brussels. Our support will remain steadfast.”

António Costa, President of the European Council, said:

In a multipolar world, the EU has an essential role to play to address global health threats and unprecedented challenges to people and communities. Vaccines availability is vital not only for humanity but also to restore global economic activity and prosperity. The forthcoming Gavi’s High Level Pledging Summit in Brussels reaffirms the EU’s commitment to build sustainable partnerships with countries in need of health security. Multilateral collaboration is vital for pandemic preparedness and responsiveness.

The European Union and Gavi: a commitment to global health solidarity  

The European Union boasts a long-standing and impactful partnership with Gavi, having committed more than €3.2 billion in total since 2003, including the COVAX Advance Market Commitment (AMC) and EIB financial instruments.

The EU and its Member States, in a Team Europe approach, remain collectively Gavi’s largest contributor, totalling more than €6.5 billion for Gavi 5.0 (2021–2025).

The Bill & Melinda Gates Foundation: co-host and leading development advocate 

As a founding member of Gavi, the Gates Foundation has been instrumental in bringing global attention to the critical importance of immunisation, and of high-powered sustainable development approaches to solve market access issues for countries. Since 2000, the Foundation has committed $6.1 billion to Gavi to improve the delivery of high-quality, affordable vaccines for more equitable coverage.

Global Citizen will be a strategic partner in supporting advocacy, campaigning and event production. As an international advocacy organisation dedicated to achieving the end of extreme poverty, powered by a community of millions of Global Citizens, Global Citizen will aim to strengthen support from leaders and citizens to act on vaccine equity, sustainable economic development, and poverty reduction.

Background

A global game-changer since 2000, Gavi, the Vaccine Alliance, has transformed global immunisation efforts by vaccinating over 1.1 billion children, saving more than 18.8 million lives from preventable diseases, and driving transformative innovations in both funding mechanisms and vaccine delivery and demand. These efforts have generated over $250 billion in economic benefits and anticipated more than 100 outbreaks.

Gavi’s 2026–2030 strategy (Gavi 6.0) is the final push to achieve global immunisation and health security targets ahead of the 2030 Sustainable Development Goals (SDG) deadline. The strategy is anchored on three key pillars: protecting the world through strengthened global health security; protecting people by vaccinating more children against more diseases at an accelerated pace; and protecting communities by reducing the number of ‘zero-dose’ children and building resilient health systems.

Central to this strategy is a commitment to country ownership and sustainability, with low- and middle-income countries projected to contribute 46% of the total vaccine cost, a significant increase from just 10% a decade ago. Over the next five years, Gavi 6.0 will deliver an estimated $100 billion in economic benefits, with more than half of its vaccine portfolio contributing to climate resilience.

The 2025 pledging Summit builds on the successful launch of Gavi’s 6.0 Investment Opportunity in June 2024 in Paris, co-hosted by France and the African Union, which raised $2.4 billion towards the $9 billion funding target of Gavi. The European Commission has already announced its pledge for Gavi 6.0 when President von der Leyen made a pledge of EUR 260 million on the sidelines of the 79th session of the United Nations General Assembly. To date, $2.8 billion has been pledged to Gavi by donors.

More information

In today’s world, addressing health challenges at the global level is more important than ever. Vaccines have a life saving power. And Gavi’s role is key for making equitable vaccine access a reality, and for empowering our partners to achieve health sovereignty. Together with Gavi, we have the goal to vaccinate 500 million children by 2030. That is why the European Union is proud to co-host Gavi’s High Level Pledging Summit in Brussels. Our support will remain steadfast.

Ursula von der Leyen, President of the European Commission

In a multipolar world, the EU has an essential role to play to address global health threats and unprecedented challenges to people and communities. Vaccines availability is vital not only for humanity but also to restore global economic activity and prosperity. The forthcoming Gavi’s High Level Pledging Summit in Brussels reaffirms the EU’s commitment to build sustainable partnerships with countries in need of health security. Multilateral collaboration is vital for pandemic preparedness and responsiveness.

António Costa, President of the European Council

When the Gates Foundation made its first investment in Gavi 25 years ago, I couldn’t have predicted the extraordinary impact it would have on combatting infectious diseases, lifting up economies, and saving lives,” said Bill Gates, chair, Gates Foundation. “The foundation is proud to join the European Union to co-host Gavi’s pledging summit, and we look forward to our continued partnership to build a safer and healthier future.

Bill Gates, Chair of the Bill & Melinda Gates Foundation

By investing in Gavi, our donors are investing in a world that is more resilient to disease outbreaks, in economies that are more capable of contributing to global growth and in the future of over half of the world’s children, whose ability to lead healthy, productive lives is so vital for the future of our planet. I am deeply grateful to our co-hosts, the European Union and the Gates Foundation, for their leadership and commitment to building a future that is safer, healthier and more prosperous for all.

José Manuel Barroso, Chair of the Board of Gavi

Source – EU Commission

 


European Commission pledges €260 million to Gavi for 2026–2027 and over €200 million in additional humanitarian aid

New York, 28 September 2024 

On September 28, the European Commission announced a new funding pledge of €260 million to Gavi, the Vaccine Alliance, for the years 2026–2027. The funds will contribute to Gavi’s goal for 2030 to help protect 500 million children around the world, strengthen immunisation systems, and boost global health security by increasing readiness to respond to disease outbreaks.

President of the European Commission Ursula von der Leyen said: ‘A healthier world is a better world. And vaccination is one of our best chances for this. Right now, millions of children are still at risk. We must continue to support vaccination around the world to save lives. So today I am proud to pledge 260 million euros for Gavi, the Vaccine Alliance. And more will come.’

In 2020, the EU pledged Gavi €300 million for the period 2021–2025. Today’s pledge of €260 million concerns the first two years of Gavi’s next strategic cycle which coincide with the last two years of the EU’s current Multiannual Financial Framework (MFF) 2021–2027. The Commission will remain committed to a high level of ambition in supporting GAVI when designing its proposal for the next MFF. This will complement strong support to Gavi from EU Member States in a Team Europe approach.

President von der Leyen also pledged €213 million in additional humanitarian aid for Africa, Afghanistan, Palestinians and Venezuela. The funding – currently subject to the approval of the Budgetary Authority – will contribute also to the fight against food insecurity in these regions. Of this total amount, €69 million will be allocated to Sudan and its neighbouring countries, in response to the dire humanitarian consequences of the Sudan war.

Background

Since 2003, the European Union has been providing increasing financial and political support to Gavi, the Vaccine Alliance, a non-profit global public-private partnership, as it works with partner countries to build up immunisation systems and increase equitable access to essential health products and primary healthcare services in poor countries. ‘Team Europe’ also plays a leading role in shaping Gavi’s strategic direction and policymaking through participation in its Board.

Between 2000 and 2022, Gavi helped vaccinate more than 1 billion children in close partnership with 78 lower-income countries, saving over 17 million lives. Today, a child born in a Gavi-supported country is 70% less likely to die from a vaccine-preventable disease before their fifth birthday than in 2000.In its next strategic cycle 2026–2030, Gavi aims to protect at least 500 million children, saving over 8 million and bring vaccines against 24 different diseases to the poorest countries in the world. For example, Gavi aims to protect over 50 million children against malaria, one of the world’s biggest killers of children under five; introduce a vaccine against dengue; and expand preventive campaigns and vaccine stockpiles against diseases like cholera and yellow fever. Gavi also intends to vaccinate over 120 million girls against the human papillomavirus (HPV) to help eliminate cervical cancer.

During the next cycle, Gavi will strengthen its role in global health security, investing in emergency stockpiles and expanding vaccine programmes to prevent outbreak-prone diseases at source. It will intensify its market shaping work and help secure access to vaccines for the poorest countries in a possible future health crisis. Gavi will also work with regional partners to build resilience in local manufacturing.

The European Union’s initial humanitarian aid budget for 2024 of €1.8 billion aims at alleviating the suffering of the more than 300 million people in need of aid around the world. Subject to the approval of the Budget Authority, these additional top ups are allocated as follows:

  • Africa – food insecurity: €41 million
  • Sudan crisis and its spillover effects on neighbouring countries: €69 million
  • Afghanistan – food insecurity: €40 million
  • Palestinians: €45 million
  • Venezuela: €18 million
More information

A healthier world is a better world. And vaccination is one of our best chances for this. Right now, millions of children are still at risk. We must continue to support vaccination around the world to save lives. So today I am proud to pledge 260 million euros for Gavi, the Vaccine Alliance. And more will come.

Ursula von der Leyen, President of the European Commission

Immunisation is a cornerstone of health security and vital to global equity. We deeply appreciate the EU’s leadership, its partnership with Gavi supported countries matching their investment in vaccine costs, and enhanced commitment to Gavi’s mission which contributes to a safer, healthier world for all.

José Manuel Barroso, Chair of the Board of Gavi

Source – EU Commission

Forward to your friends